Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
复制标题
DOI:
10.1002/emmm.201303090
复制
发表时间:
2013-08
影响因子:
11.1
通讯作者:
Gyrd-Hansen, Mads
中科院分区:
文献类型:
--
作者:
Damgaard, Rune Busk;Fiil, Berthe Katrine;Speckmann, Carsten;Yabal, Monica;zur Stadt, Udo;Bekker-Jensen, Simon;Jost, Philipp J.;Ehl, Stephan;Mailand, Niels;Gyrd-Hansen, Mads
X-linked Inhibitor of Apoptosis (XIAP) is an essential ubiquitin ligase for pro-inflammatory signalling downstream of the nucleotide-binding oligomerization domain containing (NOD)-1 and -2 pattern recognition receptors. Mutations in XIAP cause X-linked lymphoproliferative syndrome type-2 (XLP2), an immunodeficiency associated with a potentially fatal deregulation of the immune system, whose aetiology is not well understood. Here, we identify the XIAP baculovirus IAP repeat (BIR)2 domain as a hotspot for missense mutations in XLP2. We demonstrate that XLP2-BIR2 mutations severely impair NOD1/2-dependent immune signalling in primary cells from XLP2 patients and in reconstituted XIAP-deficient cell lines. XLP2-BIR2 mutations abolish the XIAP-RIPK2 interaction resulting in impaired ubiquitylation of RIPK2 and recruitment of linear ubiquitin chain assembly complex (LUBAC) to the NOD2-complex. We show that the RIPK2 binding site in XIAP overlaps with the BIR2 IBM-binding pocket and find that a bivalent Smac mimetic compound (SMC) potently antagonises XIAP function downstream of NOD2 to limit signalling. These findings suggest that impaired immune signalling in response to NOD1/2 stimulation is a general defect in XLP2 and demonstrate that the XIAP BIR2-RIPK2 interaction may be targeted pharmacologically to modulate inflammatory signalling. The X-linked lymphoproliferative syndrome type-2 is an immunodeficiency disease caused by mutations in the XIAP gene. BIR2 domain mutations in patients impair RIPK2 binding and NOD2-dependent innate immune signaling, explaining some of the pathology.
登录
查看更多内容
DOI:
10.1084/jem.20091683
发表时间:
2009-08-31
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Casanova JL;Abel L
通讯作者:
Abel L
影响因子:
32.4
作者:
Bertrand, Mathieu J. M.;Doiron, Karine;Saleh, Maya
通讯作者:
Saleh, Maya
影响因子:
64.8
作者:
Liu, ZH;Sun, CH;Fesik, SW
通讯作者:
Fesik, SW
影响因子:
16
作者:
Bertrand, Mathieu J. M.;Milutinovic, Snezana;Barker, Philip A.
通讯作者:
Barker, Philip A.
影响因子:
16
作者:
Damgaard, Rune Busk;Nachbur, Ueli;Gyrd-Hansen, Mads
通讯作者:
Gyrd-Hansen, Mads